Notable Downgrades: Raptor Pharma (RPTP), American Eagle Outfitters (AEO), Amkor Technology (AMKR), Conns Inc. (CONN)

Analysts at Citigroup (C) downgraded Raptor Pharmaceuticals Corp. (RPTP) from ‘Buy’ to ‘Neutral’ in a research report issued to clients on Tuesday.

The target price for RPTP is lowered from $20 to $8 following topline results from company’s Phase 2b CyNCh study, which did not meet its primary endpoint of improving nonalcoholic steatohepatitis in children.

On valuation measures, Raptor Pharmaceutical Corp. stock have a t-12-month revenue of $84.83 million. RPTP ‘s ROE for the same period is (84.44%).

Shares of the $572.32 million market cap company are down 32.50% year-over-year and 28.52% year-to-date.

Raptor Pharmaceutical Corp., currently with a median Wall Street price target of $17.00 and a high target of $34.00, dropped $0.47 to $7.05 in recent trading.

American Eagle Outfitters, Inc. (AEO) was downgraded from ‘Buy’ to ‘Neutral’ and the price target was cut to $18 from $21 at B. Riley & Co.

Shares have traded today between $15.15 and $15.73 with the price of the stock fluctuating between $11.77 to $18.49 over the last 52 weeks.

American Eagle Outfitters Inc. shares are currently changing hands at 22.43x this year’s forecasted earnings, compared to the industry’s 18.52x earnings multiple. Ticker has a t-12 price/sales ratio of 0.89. EPS for the same period registers at $0.68.

Shares of American Eagle Outfitters have lost $0.37 to $15.30 in mid-day trading on Tuesday, giving it a market cap of roughly $3 billion. The stock traded as high as $18.49 in August 18, 2015.

Citigroup reported on Tuesday that they have lowered their rating for Amkor Technology, Inc. (AMKR). The firm has downgraded AMKR from ‘Buy’ to ‘Neutral’ and lowered its price target to $5.80 from $7.00.

Amkor Technology Inc. recently traded at $5.19, a loss of $0.10 over Monday’s closing price. The name has a current market capitalization of $1.23 billion.

Conns Inc. (CONN) had its rating lowered from ‘Buy’ to ‘Hold’ by analysts at Stifel on Tuesday. Currently there are 4 analysts that rate CONN a ‘Buy’ versus 3 rating it a ‘Hold’. No analysts rate it a ‘Sell’.

CONN was down $0.23 at $27.69 in mid-day trade, moving within a 52-week range of $14.02 to $43.95. The name, valued at $1.01 billion, opened at $26.59.

On valuation measures, Conn’s Inc. shares are currently priced at 22.88x this year’s forecasted earnings. Ticker has a t-12 price/sales ratio of 0.65. EPS for the same period registers at $1.21.

Be the first to comment

Leave a Reply

Your email address will not be published.


*